CTSD and cancer: Cathepsin B and Cathepsin D release into the cytosol promoted the cleavage and activation of BID, and Dcf1 also decreased the expression of Bcl‐2 to induce the release of proapoptotic factors and enhance the levels of cancer suppressors.